COBRE : SIGNIFICANT NEW COPPER INTERSECTION AT THE NGAMI COPPER PROJECT
Last Wednesday Cobre (ASX:CBE) announced a significant new copper intersection at the Ngami Copper Project in Botswana. The project is… Read more
Last Wednesday Cobre (ASX:CBE) announced a significant new copper intersection at the Ngami Copper Project in Botswana. The project is… Read more
ACTIVITY REPORT – JUNE QUARTER 2022 KEY HIGHLIGHTS DURING THE QUARTER • 16% higher Monthly Recurring Revenue (MRR) in June… Read more
Melbourne, Australia, July 27, 2022 – Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or… Read more
Highlights: • Cholesterol-Lowering Program: – Nyrada’s PCSK9 inhibitor shown to block the early stages of atherosclerosis in a novel human… Read more
Highlights: • Bellberry human research ethics committee approved the phase 1 clinical trial investigating safety and pharmacokinetics of IHL-675A on… Read more
Highlights: • Bellberry human research ethics committee approved the phase 1 clinical trial investigating safety and pharmacokinetics of IHL-675A on… Read more
July 20, 2022 Nyrada Inc. (ASX:NYR) released an announcement headed “Nyrada’s PCSK9 Inhibitor Evaluated in Novel Model of Atherosclerosis”. We… Read more
HIGHLIGHTS: • Continued momentum in demand for Infinity products with increasing monthly recurring revenue and high-volume sales pipeline for Infinity… Read more
• Cholesterol-Lowering Program preclinical safety and toxicology studies remain on track to commence Q3 CY2022 • COVID-related lockdowns in Shanghai… Read more